SENSITIZING FOR CIS-DIAMMINEDICHLOROPLATINUM(II) ACTION BY HYPERTHERMIA IN RESISTANT CELLS

被引:26
作者
KONINGS, AWT [1 ]
HETTINGA, JVE [1 ]
LEMSTRA, W [1 ]
HUMPHREY, GB [1 ]
KAMPINGA, HH [1 ]
机构
[1] UNIV GRONINGEN,DEPT PEDIAT ONCOL,9713 BZ GRONINGEN,NETHERLANDS
关键词
HYPERTHERMIA; CISPLATIN; DRUG RESISTANCE; THERMOCHEMO-SENSITIZATION; GLUTATHIONE;
D O I
10.3109/02656739309005052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
cDDP-resistant Ehrlich ascites tumour (EAT) cells (ER cells) were tested for cellular content of total glutathione, heat sensitivity, cDDP sensitivity and synergistic effects of a combined treatment of heat and chemotherapy. In comparison with the non-resistant EAT cells (EN) the ER cells had an elevated level of glutathione. Treatment With D,L-buthionine-(S,R)-sulphoximine (BSO), resulting in almost complete depletion of cellular glutathione, did not cause drug sensitization. The ER cells were somewhat less heat sensitive compared with the EN cells. Heat chemosensitization was observed for the EN cells as well as for the ER cells. At 43-degrees-C (but not at 42-degrees-C) the thermal enhancement ratio (TER) for cDDP toxicity was significantly higher in the ER cells. The total number of cells killed by the combined treatment was less in the ER cells than in the EN cells. After analysing existing literature, combined with the current results, it is concluded that although cDDP-resistant cells can often considerably be chemosensitized by hyperthermia, in most cases the difference in cDDP sensitivity cannot be overcome totally. In those situations where cDDP-resistant cells are more sensitive to heat and also show a high TER, especially at clinically relevant temperatures, hyperthermia as added modality is indicated for clinical treatment.
引用
收藏
页码:553 / 562
页数:10
相关论文
共 21 条
[1]   HEAT SENSITIZATION TO CISPLATIN IN 2 CELL-LINES WITH DIFFERENT DRUG SENSITIVITIES [J].
EICHHOLTZWIRTH, H ;
HIETEL, B .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1990, 6 (01) :47-55
[2]  
Engelhardt R, 1987, Recent Results Cancer Res, V104, P136
[3]  
FREEMAN ML, 1990, CANCER RES, V50, P5296
[4]  
HAHN GM, 1982, HYPERTHERMIA CANCER
[5]  
HAHN GM, 1978, CANCER THERAPY HYPER
[6]   AUGMENTATION OF ADRIAMYCIN, MELPHALAN, AND CISPLATIN CYTO-TOXICITY IN DRUG-RESISTANT AND DRUG-SENSITIVE HUMAN OVARIAN-CARCINOMA CELL-LINES BY BUTHIONINE SULFOXIMINE MEDIATED GLUTATHIONE DEPLETION [J].
HAMILTON, TC ;
WINKER, MA ;
LOUIE, KG ;
BATIST, G ;
BEHRENS, BC ;
TSURUO, T ;
GROTZINGER, KR ;
MCKOY, WM ;
YOUNG, RC ;
OZOLS, RF .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2583-2586
[7]   RATIONALE FOR USE OF LOCAL HYPERTHERMIA WITH RADIATION-THERAPY AND SELECTED ANTICANCER DRUGS IN LOCALLY ADVANCED HUMAN MALIGNANCIES [J].
HERMAN, TS ;
TEICHER, BA ;
JOCHELSON, M ;
CLARK, J ;
SVENSSON, G ;
COLEMAN, CN .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1988, 4 (02) :143-158
[8]  
HERMAN TS, 1988, CANCER RES, V48, P5101
[9]  
HOSPERS GAP, 1988, CANCER RES, V48, P6803
[10]   INTERACTION OF HYPERTHERMIA AND RADIATION IN TOLERANT AND NONTOLERANT HELA S3 CELLS - ROLE OF DNA-POLYMERASE INACTIVATION [J].
KAMPINGA, HH ;
KEIJ, JF ;
VANDERKRUK, G ;
KONINGS, AWT .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1989, 55 (03) :423-433